Dapagliflozin Trial
Phase 1/2
60
about 2.7 years
18–85
1 site in IL
Why this study is shown
What this study is about
Researchers are testing if dapagliflozin, a medication for diabetes, can change the way your heart and lungs work in people with chronic kidney disease. The trial will also look at changes in substances created when our bodies break down food, drugs, or its own tissues.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Dapagliflozin 10 MG [Farxiga]
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You are randomly assigned, but you will know your treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
dapagliflozin, antidiabetic (Dapagliflozin (SGLT2 inhibitor))
oral (Oral Tablet)
Renal, Cardiology / Heart